HIL – Human Insight Israel, Israel

Registration Status: Completed

Objective: Human Insight Israel (HIL) is an Israel Innovation Authority–funded national biobank capturing clinical and large-scale proteomic data at the Emergency Department timepoint, across three Israeli hospitals. The program is led by MeMed Diagnostics and aims to enroll 10,000 patients stepwise by clinical domain (2,000 per domain), starting with acute infectious diseases. Plasma samples undergo deep proteomic profiling, paired with harmonized clinical data. HIL is designed to lower the barrier to early-stage proteomic discovery in acute care, a setting under-represented in existing biobank infrastructure.

Registered Biobank Name HIL – Human Insight Israel
Biobank Leader Eran Reiner, MD
Country Israel
Email for biobank inquiries eran.reiner@me-med.com
Principal Investigator Eran Reiner, MD
Website
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Biospecimen Collected:
Cohort Highlights